Evidence map›Paper›PMID 23738336›Full record

ArticleBioMed research international2013

Revealing the mechanism of in vitro wound healing properties of Citrus tamurana extract.

Madhyastha Harishkumar, Yamaguchi Masatoshi, Sameshima Hiroshi, Ikenoue Tsuyomu, Maruyama Masugi

Abstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. A comparative assessment ofRSC advances · 2021
    Article
  6. Article
  7. Article
  8. Heliyon · 2019
    Article
  9. Article
  10. Article
  11. Evidence-based complementary and alternative medicine : eCAM · 2017
    Article
  12. Determination of the Wound Healing Potentials of Medicinal Plants Historically Used in Ghana.Evidence-based complementary and alternative medicine : eCAM · 2017
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Madhyastha HarishkumarDepartment of Applied Physiology, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan. hkumar@med.miyazaki-u.ac.jp
Yamaguchi Masatoshi
Sameshima Hiroshi
Ikenoue Tsuyomu
Maruyama Masugi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present investigation, we examined the effect of Hyuganatsu (Citrus tamurana) extract (HE) on skin fibroblast (TIG-119) proliferation and migration during in vitro wound healing. HE selectively inhibited proliferation of TIG-119 cells at higher concentration (>1.0 mg/mL); at lower concentrations (0.1, 0.25, 0.5, and 0.75 mg/mL), it exhibited linear and time-dependent cell proliferation. In vitro scratch wound healing studies showed that the HE also accelerated the migration of cells towards the wounded region. Cytometric analysis demonstrated that HE extract did not alter G1/0 and S phases of cell cycle in any concentration studied; however, G2/M phases of cell cycle were significantly (P < 0.05) accelerated at 0.75 mg/mL dose. RT-PCR and Western blotting analysis indicated that HE markedly overexpressed levels of Rac-1, Rho-A, and Cdc-42 mRNA and the respective proteins. Cyclin-dependent kinases (Cdk-1 and -2) gene expression activity was significantly (P < 0.05) increased, but protein content decreased during treatment with HE. The induction of Cdk-1 and -2 by HE was abolished by inhibitors, transcription (DRB), and translation (CHX), implying transcriptional regulation that required de novo protein synthesis.

Indexed as

Cell DeathCell DivisionCell LineCell MovementCell ProliferationCitrusCyclin-Dependent KinasesFibroblastsG2 PhaseGene Expression RegulationHumansPlant ExtractsProtein Biosynthesisrho GTP-Binding ProteinsRNA, MessengerTranscription, GeneticCyclin-Dependent KinasesPlant Extractsrho GTP-Binding ProteinsRNA, Messenger

Identifiers

PMID23738336
PMCPMC3659433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.